DNA ploidy, S-phase fraction and associations with 2-¹⁸F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma

References

• Mohr C, Molls M, Streffer C, Pelzer T. Prospective flow cytometric analysis of head and neck carcinomas. Prognostic relevance of DNA-content and S-fraction. J Craniomaxillofac Surg 1992; 1: 8–13.
   Google Scholar
• Begg A, Haustermanns K, Hart A, Dische S, Saunders M, Zackrisson B, et al. The value of pre-treatment cell kinetic parameters as predictors for radiotherapy out-come in head and neck cancer: a multicentric analysis. Radiother Oncol 1999; 50: 13–23.
   PubMed Web of Science ®Google Scholar
• Alsner J, }Myer M, Berg Sorensen S, Overgaard J. Interaction between potential doubling time and TP 53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2001; 49: 519–25.
   Google Scholar
• Ensley J, Maciorowski Z, Hassan M, Pietraszkiewicz H, Heibrun L, Kish J, et al. Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry 1989; 10: 334–8.
   PubMedGoogle Scholar
• Joensuu H. DNA flow cytometry in the prediction of survival and response to radiotherapy in head and neck cancer. Acta Oncol 1990; 29: 513–6.
   PubMed Web of Science ®Google Scholar
• Hemmer J, Nagel E, Kraft K. DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavity. Anticancer Res 1999; 19: 1419–22.
   Google Scholar
• Ensley J, Maciorowski Z, Pietraszkiewicz H, deBraud F, Sakr W. Methodology and clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck. In: Jacobs, editor. Carcinomas of the head and neck. Dordrecht, The Netherlands: Kluwer; 1990. p. 225–42.
   Google Scholar
• Franzén G, Olofsson J, Tytor M, Klintenberg C, Risberg B. Preoperative irradiation in oral cavity carcinomas. A study with special reference to DNA pattern, histologi-cal response and prognosis. Acta Oncol 1987; 26: 349–55.
   Google Scholar
• Ensley J, Maciorowski Z. Clinical applications of DNA content parameters in patients with squamous cell cancers of the head and neck. Semin Oncol 1994; 21: 330–9.
   PubMedGoogle Scholar
• Tennvall J, Wennerberg J, Anderson H, Baldetorp B, Ferno M, Willén R. DNA analysis as a predictor of the outcome of induction chemotherapy in advanced head and neck carcinomas. Arch Otolaryngol Head Neck Surg 1993; 119: 867–70.
   Google Scholar
• Flier J, Mueckler M, Usher P, Lodish H. Elevated levels of glucose transport and transport messenger RNA are induced by ras or src oncogenes. Science 1987; 235: 1492–5.
   PubMed Web of Science ®Google Scholar
• Higashi K, Clavo A, Wahl R. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tri-tiated thymidine uptake. J Nucl Med 1993; 34: 414–9.
   Google Scholar
• Brun E, Kjellén E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002; 24: 127–35.
   PubMed Web of Science ®Google Scholar
• Baisch H, Gohde W, Lindem WA. Analysis of PCP-data to determine the fraction of cells in various phases of cell cycle. Radiat Environ Biophys 1975; 12: 31–9.
   Google Scholar
• Baldetorp B, Bendahl P-O, Fernö M, Alanen K, Delle U, Falkmer U et al. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cyto-metry 1995; 22: 13–23.
   Google Scholar
• Gaub J, Auer G, Zetterberg A. Quantitative cytochem-ical aspects of a combined feulgen-naphthol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp Cell Res 1975; 92: 323–32.
   Google Scholar
• Auer G, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980; 2: 161–5.
   PubMedGoogle Scholar
• Rhodes C, Wise R. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 1983; 14: 614–26.
   PubMed Web of Science ®Google Scholar
• Gandour-Edwards RF, Donald PJ, Yu TL, Howard RR, Teplitz RL. DNA content of head and neck carcinoma by flow and image cytometry. Arch Otolaryngol Head Neck Surg 1994; 120: 294–7.
   Google Scholar
• Faranda A, Costa A, Canova S, Abolafio G, Silvestrini R. Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study. Anal Quant Cytol Histol 1987; 19: 338–44.
   Google Scholar
• Zhang Y, LeRiche JC, Jackson SM, Garner D, Placic B. An automated image cytometry system for monitoring DNA ploidy and other features of radiotherapy and chemotherapy patients. Radiat Med 1999; 17: 45–57.
   Google Scholar
• Falkmer U, Hagmar T, Auer G. Efficacy of combined image and flow cytometric DNA assessments in human breast cancer. Anal Cell Pathol 1990; 2: 297–312.
   Google Scholar
• Polackova J, Hemmer J. Progression of diploid tumor cells in aneuploid head and neck squamous cell carci-nomas. Int J Oncol 1999; 15: 315–20.
   PubMedGoogle Scholar
• Welkoborsky H, Mann WJ, Sanal C, Freije J. DNA measurements for monitoring chemotherapy in ad-vanced head and neck carcinomas. Head Neck 1994; 16: 240–5.
   PubMedGoogle Scholar
• Minn H, Clavo A, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squa-mous cell carcinomas of the head and neck. J Nud Med 1995; 36: 252–8.
   Google Scholar
• Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nud Med 1993; 34: 12–7.
   Google Scholar